Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Phase II study begun for Zhifei Longcom's recombinant coronavirus vaccine

Aug. 4, 2020

Innovative phase III study assesses LY-CoV555 for preventing SARS-CoV-2 infection in care facilities

Aug. 4, 2020

Roche patents new HBV antivirals

Aug. 4, 2020

Phase II trial of VIR-2218 plus peg-IFN-alfa 2a recruits patients with HBV infection

Aug. 4, 2020

Phase III trial approved for RHB-204 for nontuberculous mycobacteria infections

Aug. 3, 2020

WARF presents new antifungal compounds

Aug. 3, 2020

First mouse-adapted strain of SARS-CoV-2

Aug. 3, 2020

SAB initiates phase I trial of SAB-176 for treatment of seasonal influenza

Aug. 3, 2020

J&J initiates first-in-human study with Ad26.COV2.S vaccine candidate against SARS-COV-2

July 31, 2020

Constant Therapeutics initiates phase II study of TXA-127 for COVID-19

July 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...